Biology

New Network Sets Gold Standard for Detecting Cancer-Causing Mutations

How the science connects

DNA sequencingCancer genomicsSomatic mutation

AI Insight

The Somatic Mosaicism across Human Tissues (SMaHT) Network has conducted comprehensive benchmarking showing that current sequencing technologies and analytical methods can now systematically detect somatic mutations across the entire genome in healthy, non-cancerous tissues. The study demonstrates improved capability to identify diverse types of somatic mutations, from telomere to telomere, representing a significant advancement in understanding genetic variation that occurs after conception in normal human tissues.


This research enables better understanding of how somatic mutations accumulate in healthy tissues throughout life, which has implications for studying aging, disease predisposition, and the origins of cancer. The validated methods provide a foundation for large-scale studies of somatic mosaicism in human health and disease.


Benchmarking by the Somatic Mosaicism across Human Tissues Network demonstrates that advances in sequencing and analysis now enable systematic and comprehensive discovery of somatic mutations across diverse mutation types in non-cancerous tissues and across the genome from telomere to telomere.

Source: Comprehensive benchmarking of somatic mutation detection by the SMaHT Network